There are 2137 resources available
199P - Relation between CYP2D6 polymorphisms and survival in breast cancer treated with tamoxifen
Presenter: Silvia Rubio Novella
Session: E-Poster Display
Resources:
Abstract
200P - Lipid changes during endocrine therapy in breast cancer patients: The results of a 5-year real-world retrospective analysis
Presenter: Tao He
Session: E-Poster Display
Resources:
Abstract
201P - 70-gene signature to select breast cancer patients for neoadjuvant endocrine treatment
Presenter: Chaja Feige Jacobs
Session: E-Poster Display
Resources:
Abstract
202P - Role of micrometastases in sentinel lymph node biopsy after neoadjuvant chemotherapy in breast cancer patients
Presenter: Jose Ponce
Session: E-Poster Display
Resources:
Abstract
203P - Comparison of two pathologic response evaluation classification after neoadjuvant chemotherapy in patients with breast cancer
Presenter: Jose Ponce
Session: E-Poster Display
Resources:
Abstract
204P - Metformin with neoadjuvant chemotherapy in stage II-III breast cancer: A phase II clinical trial
Presenter: Hend Azazy
Session: E-Poster Display
Resources:
Abstract
205P - Influence of green tea consumption on endoxifen steady-state concentration in breast cancer patients treated with tamoxifen
Presenter: Louwrens Braal
Session: E-Poster Display
Resources:
Abstract
206P - Significance of the effects of chemotherapy on programmed death-ligand 1 expression in triple negative breast cancer
Presenter: Seiichi Imanishi
Session: E-Poster Display
Resources:
Abstract
207P - 10-year real-world outcomes with neoadjuvant systemic therapy in non-inflammatory breast cancer
Presenter: Anja Kovac
Session: E-Poster Display
Resources:
Abstract
208P - Treatment outcomes in early breast cancer patients undergoing neoadjuvant chemotherapy in a multidisciplinary setting. An analysis of 273 patients
Presenter: Teresa Smit
Session: E-Poster Display
Resources:
Abstract